Details for 2017718256

Up to date per 01.04.2026

Actions

Title / Product Name

FLÜSSIGE FORMULIERUNGEN VON (S)-N-(5-((R)-2-(2,5-DIFLUORPHENYL)-PYRROLIDIN-1-YL)-PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDIN-1-CARBOXAMID

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017718256

EP Publication Number

3439662

E-Number

1705665

Language

PCT Number

US17025939

Publication Date

13.02.2019 A

24.07.2024 B1

Registration Date

24.07.2024

AT Publication Date

15.08.2024

Application Date

04.04.2017

Registration Number

Priorities

04.04.2016

201662318041 P

15.04.2016

201662323452 P

29.04.2016

201662329561 P

IPC

A61K 31/519 20060101AFI20171013BHEP

Maximum Duration of Protection

04.04.2037

Owner

Loxo Oncology, Inc.281 Tresser Boulevard 9th Floor Stamford, Connecticut 06901US

Representative

Paul CosmoviciGumpendorfer Straße 1421060 WienAT

Inventor

REYNOLDS, Mark281 Tresser Blvd. 9th Floor Stamford Connecticut 06901US

SMITH, Steven A.281 Tresser Blvd. 9th Floor Stamford Connecticut 06901US

Information about Fees